GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » Price-to-Free-Cash-Flow

Intercure (XTAE:INCR) Price-to-Free-Cash-Flow : N/A (As of Dec. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Intercure Price-to-Free-Cash-Flow?

As of today (2024-12-12), Intercure's share price is ₪4.953. Intercure's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.24. Hence, Intercure's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Intercure's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Intercure's highest Price-to-Free-Cash-Flow Ratio was 900.00. The lowest was 43.36. And the median was 123.28.

XTAE:INCR's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 26.44
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Intercure's Free Cash Flow per Share for the three months ended in Jun. 2024 was ₪0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₪-1.24.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -34.30% per year.

During the past 13 years, Intercure's highest 3-Year average Free Cash Flow per Share Growth Rate was 66.90% per year. The lowest was -170.70% per year. And the median was -27.40% per year.


Intercure Price-to-Free-Cash-Flow Historical Data

The historical data trend for Intercure's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Price-to-Free-Cash-Flow Chart

Intercure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 61.71 17.01 -

Intercure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.01 - - - -

Competitive Comparison of Intercure's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intercure's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Intercure's Price-to-Free-Cash-Flow falls into.



Intercure Price-to-Free-Cash-Flow Calculation

Intercure's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.953/-1.244
=N/A

Intercure's Share Price of today is ₪4.953.
Intercure's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-1.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Intercure  (XTAE:INCR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Intercure Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Intercure's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Intercure Business Description

Traded in Other Exchanges
Address
85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.